230 related articles for article (PubMed ID: 7044244)
1. Antiplatelet agents: their role in the prevention of sudden death.
Hirsh J
Ann N Y Acad Sci; 1982; 382():289-304. PubMed ID: 7044244
[No Abstract] [Full Text] [Related]
2. Platelets and antiplatelet therapy in ischemic heart disease.
Frishman WH; Miller KP
Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576
[No Abstract] [Full Text] [Related]
3. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Genton E
Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
[No Abstract] [Full Text] [Related]
4. Platelets and prostaglandins in sudden death: therapeutic implications.
Gelman JS; Mehta J
Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
[No Abstract] [Full Text] [Related]
5. Cardiac death prevention in post-myocardial infarction patients: a review.
Boissel JP; Leizorovicz A; Faucomprez C
Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
[No Abstract] [Full Text] [Related]
6. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
McNicol GP
Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840
[No Abstract] [Full Text] [Related]
7. Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
Van Aken WG
Adv Cardiol; 1982; 31():98-101. PubMed ID: 6758512
[No Abstract] [Full Text] [Related]
8. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Hirsh J
Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
[TBL] [Abstract][Full Text] [Related]
9. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
10. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
11. Antiplatelet drugs after acute myocardial infarction.
Mannucci PM
Ric Clin Lab; 1984; 14(1):1-7. PubMed ID: 6729352
[No Abstract] [Full Text] [Related]
12. Role of platelet-active drugs in coronary artery disease.
Sherry S
Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
[No Abstract] [Full Text] [Related]
13. Myocardial infarction.
Prentice CR
Clin Haematol; 1981 Jun; 10(2):521-41. PubMed ID: 7032787
[No Abstract] [Full Text] [Related]
14. Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Verstraete M
Acta Clin Belg; 1976; 31(4):229-32. PubMed ID: 1087523
[No Abstract] [Full Text] [Related]
15. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
16. Platelet tests and antiplatelet drugs in coronary artery disease.
de Boer AC; Han P; Turpie AG; Butt R; Gent M; Genton E
Circulation; 1983 Mar; 67(3):500-4. PubMed ID: 6217921
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
Gitler B; Gitler ES
Am Heart J; 1983 Sep; 106(3):563-70. PubMed ID: 6410893
[No Abstract] [Full Text] [Related]
18. Antiplatelet agents: a review.
Gantmacher ML
J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644
[No Abstract] [Full Text] [Related]
19. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
20. Deposition of human labeled platelets to damaged rabbit aorta before and after use of sulfinpyrazone in patients with acute myocardial infarction.
Jaeger S; Berntsen H
Haemostasis; 1980; 9(5):257-62. PubMed ID: 7409611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
